JBC Ideal method for primary cell transfection

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cheifetz, S.
Right arrow Articles by Massague, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cheifetz, S.
Right arrow Articles by Massague, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 266, Issue 31, 20767-20772, Nov, 1991

Isoform-specific transforming growth factor-beta binding proteins with membrane attachments sensitive to phosphatidylinositol-specific phospholipase C

S Cheifetz and J Massague
Cell Biology and Genetics Program, Memorial Sloan Kettering Cancer Center, New York, New York 10021.

We report the identification of cell surface glycoproteins that bind transforming growth factor-beta (TGF-beta) in an isoform-specific manner, and are distinct from TGF-beta receptors I and II or the TGF- beta binding proteoglycan beta-glycan. The novel TGF-beta binding proteins have been identified in various cell lines including fetal bovine heart endothelial cells and MG-63 human osteosarcoma cells. They include proteins of 90-100 and 180 kDa that preferentially bind TGF- beta 1 (KD 0.1-0.2 nM) and proteins of 60 and 140 kDa that preferentially bind TGF-beta 2 (KD 0.5-1 nM). The 180-kDa TGF-beta 1 binding protein and the 60- and 140-kDa TGF-beta 2 binding proteins can be released from the cell surface by treatment with phosphatidylinositol-specific phospholipase C, suggesting that these proteins are attached to the plasma membrane through a phosphatidylinositol anchor. The expression of these three proteins as well as their sensitivity to phosphatidylinositol-specific phospholipase C is cell line-dependent. The 90-100-kDa TGF-beta 1 binding proteins are components of a 190-kDa disulfide-linked complex. The structural properties of these proteins and their high affinity and selectivity for different TGF-beta isoforms defines them as a novel class of cell surface TGF-beta binding proteins.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
FASEB J.Home page
K. W. Finnson, B. Y. Y. Tam, K. Liu, A. Marcoux, P. Lepage, S. Roy, A. A. Bizet, and A. Philip
Identification of CD109 as part of the TGF-{beta} receptor system in human keratinocytes
FASEB J, July 1, 2006; 20(9): 1525 - 1527.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
J. C. Langer, E. Henckaerts, J. Orenstein, and H.-W. Snoeck
Quantitative Trait Analysis Reveals Transforming Growth Factor-{beta}2 as a Positive Regulator of Early Hematopoietic Progenitor and Stem Cell Function
J. Exp. Med., January 5, 2004; 199(1): 5 - 14.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Y. Y. Tam, K. W. Finnson, and A. Philip
Glycosylphosphatidylinositol-anchored Proteins Regulate Transforming Growth Factor-{beta} Signaling in Human Keratinocytes
J. Biol. Chem., December 5, 2003; 278(49): 49610 - 49617.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
H. Chang, C. W. Brown, and M. M. Matzuk
Genetic Analysis of the Mammalian Transforming Growth Factor-{beta} Superfamily
Endocr. Rev., December 1, 2002; 23(6): 787 - 823.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. A. Harrison, P. G. Farnworth, K. L. Chan, P. G. Stanton, G. T. Ooi, J. K. Findlay, and D. M. Robertson
Identification of Specific Inhibin A-Binding Proteins on Mouse Leydig (TM3) and Sertoli (TM4) Cell Lines
Endocrinology, April 1, 2001; 142(4): 1393 - 1402.
[Abstract] [Full Text]


Home page
FASEB J.Home page
E. PIEK, C.-H. HELDIN, and P. TEN DIJKE
Specificity, diversity, and regulation in TGF-{beta} superfamily signaling
FASEB J, December 1, 1999; 13(15): 2105 - 2124.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
R. G. Wells, L. Gilboa, Y. Sun, X. Liu, Y. I. Henis, and H. F. Lodish
Transforming Growth Factor-beta Induces Formation of a Dithiothreitol-resistant Type I/Type II Receptor Complex in Live Cells
J. Biol. Chem., February 26, 1999; 274(9): 5716 - 5722.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
L. Gilboa, R. G. Wells, H. F. Lodish, and Y. I. Henis
Oligomeric Structure of Type I and Type II Transforming Growth Factor beta  Receptors: Homodimers Form in the ER and Persist at the Plasma Membrane
J. Cell Biol., February 23, 1998; 140(4): 767 - 777.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Yamashita, T. Okadome, P. Franzén, P. t. Dijke, C.-H. Heldin, and K. Miyazono
A Rat Pituitary Tumor Cell Line (GH(3)) Expresses Type I and Type II Receptors and Other Cell Surface Binding Protein(s) for Transforming Growth Factor-beta
J. Biol. Chem., January 13, 1995; 270(2): 770 - 774.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
S Daopin, K. Piez, Y Ogawa, and D. Davies
Crystal structure of transforming growth factor-beta 2: an unusual fold for the superfamily
Science, July 17, 1992; 257(5068): 369 - 373.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1991 by the American Society for Biochemistry and Molecular Biology.